Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement-sensitive red cells in aplastic anemia.

I Ben-Bassat, F Brok-Simoni, B Ramot

    Blood
    |September 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Invasive Aspergillosis in Neutropenic Patients with Hematological Disorders.

    Leukemia & lymphoma·2016
    Same author

    Haemoglobin O in An Arab Family.

    British medical journal·2010
    Same author

    Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.

    Bone marrow transplantation·2007
    Same author

    Graft-versus-leukemia in chronic lymphocytic leukemia.

    Bone marrow transplantation·2007
    Same author

    Extramedullary disease and targeted therapies for hematological malignancies--is the association real?

    Annals of oncology : official journal of the European Society for Medical Oncology·2006
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    Same journal

    Is low a go for pediatric AML?

    Blood·2026
    See all related articles

    Aplastic anemia patients often have young red blood cells sensitive to complement lysis, similar to paroxysmal nocturnal hemoglobinuria. This suggests an underlying complement sensitivity in most aplastic anemia cases.

    Area of Science:

    • Hematology
    • Immunology
    • Red blood cell disorders

    Background:

    • Aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) share clinical associations.
    • Understanding the underlying mechanisms connecting these conditions is crucial.

    Purpose of the Study:

    • To investigate the complement-dependent lysis of red blood cells in aplastic anemia patients.
    • To determine if a complement-sensitive red cell population exists in AA, similar to PNH.

    Main Methods:

    • Studied complement-dependent lysis of the youngest red blood cells from aplastic anemia patients.
    • Compared findings with normal controls and patients with other hematologic disorders.

    Main Results:

    • A complement-sensitive population of young red blood cells was identified in 5 out of 6 AA patients.

    Related Experiment Videos

  • These sensitive cells were rapidly cleared from circulation and absent in older cell fractions.
  • Such cells were not found in normal controls or other hematologic disorders, except PNH.

    • Conclusions:

    • Most aplastic anemia patients possess a population of dyserythropoietic, short-lived, complement-sensitive red blood cells.
    • This finding suggests an intrinsic cellular defect or complement dysregulation in AA, even without overt PNH symptoms.